Table 1.
Baseline | After vitamin K1 (10 mg/day)* | After vitamin K1 (20 mg/day)† | Normal values | Hemostatic level (%) | |
---|---|---|---|---|---|
Prothrombin activity (%) | 11 | 36 | 42 | 70-100 | |
Ratio of APTT | 1.65 | 1.24 | 1.02 | 0.84-1.21 | |
Factor II (%) | 26 | 46 | 38 | 50-150 | 20-30 |
Factor VII (%) | <1 | 21 | 37 | 50-150 | 15-20 |
Factor IX (%) | 12 | 53 | 54 | 50-150 | 10-40 |
Factor X (%) | 13 | 27 | 31 | 50-150 | 15-20 |
Factor V (%) | 80 | 50-150 | |||
Protein C (%) | 7 | 13 | 21 | 70-140 | |
Protein S (%) | 10 | 6 | 8 | 60-120 | |
dp-ucMGP (pM) | 2387 | 2750 | 2407 | 32-546‡ |
Taking daily oral doses of 10 mg of vitamin K1 over 3 months.
Taking daily oral doses of 20 mg of vitamin K1 for more than 1 year, plus taking daily doses of 41 mg of MK-4 and 2 mg of MK-7 over 6 months.
Median value is 172.10